ALECTOR INC. - COMMON STOCK

Alector Announces Results from AL002 INVOKE-2 Phase 2 Trial in Individuals with Early Alzheimer’s Disease and Provides Business Update

25 ноя 2024 15:05:00 Источник Nasdaq GlobeNewswire

Alector Secures Flexible Credit Facility for Up to $50 Million From Hercules Capital

14 ноя 2024 15:05:46 Источник Nasdaq GlobeNewswire

Alector Reports Third Quarter 2024 Financial Results and Provides Business Update

06 ноя 2024 15:05:00 Источник Nasdaq GlobeNewswire

Alector Presents Baseline Characteristics for Pivotal INFRONT-3 Phase 3 Clinical Trial at the 14th International Conference on Frontotemporal Dementias (ISFTD 2024)

19 сен 2024 07:00:00 Источник Nasdaq GlobeNewswire

Alector to Participate in Upcoming Healthcare Conferences

29 авг 2024 06:00:00 Источник Nasdaq GlobeNewswire

Alector Reports Second Quarter 2024 Financial Results and Provides Business Update

07 авг 2024 15:05:00 Источник Nasdaq GlobeNewswire

Alector to Host Mid-Year Earnings Conference Call

31 июл 2024 15:05:00 Источник Nasdaq GlobeNewswire

Alector Presents Baseline Characteristics for INVOKE-2 Phase 2 Clinical Trial of AL002 at the Alzheimer's Association International Conference® 2024 (AAIC®)

28 июл 2024 07:05:00 Источник Nasdaq GlobeNewswire

Alector to Present Data on Pipeline Focus Areas at the Alzheimer's Association International Conference® (AAIC®) 2024

23 июл 2024 06:00:00 Источник Nasdaq GlobeNewswire

Alector to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

20 июн 2024 06:00:00 Источник Nasdaq GlobeNewswire

Alector to Host Virtual Research and Development Event Highlighting Alector Brain Carrier Blood-Brain Barrier Technology Platform

10 июн 2024 06:00:00 Источник Nasdaq GlobeNewswire

Alector to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

03 июн 2024 06:00:00 Источник Nasdaq GlobeNewswire

Alector to Participate in Upcoming Healthcare Conferences

09 май 2024 06:00:00 Источник Nasdaq GlobeNewswire

Alector Reports First Quarter 2024 Financial Results and Provides Business Update

08 май 2024 15:05:01 Источник Nasdaq GlobeNewswire

Alector to Participate in Upcoming Healthcare Conferences

28 фев 2024 06:00:00 Источник Nasdaq GlobeNewswire

Alector Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

27 фев 2024 15:05:00 Источник Nasdaq GlobeNewswire

Alector to Host Fourth Quarter and Full-Year 2023 Earnings Call

20 фев 2024 15:05:00 Источник Nasdaq GlobeNewswire

Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer’s Disease

08 фев 2024 06:00:00 Источник Nasdaq GlobeNewswire

FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)

07 фев 2024 06:00:00 Источник Nasdaq GlobeNewswire

Alector Announces Closing of Public Offering

19 янв 2024 08:20:36 Источник Nasdaq GlobeNewswire